Text Size

Respiratory Health of Elite Athletes (cold air)

This study has been completed.
Sponsor:
Information provided by:
Laval University
ClinicalTrials.gov Identifier:
NCT00686491
First received: May 26, 2008
Last updated: February 21, 2011
Last verified: February 2011
History of Changes

May 26, 2008
February 21, 2011
June 2007
December 2010   (final data collection date for primary outcome measure)
Not Provided
Not Provided
Complete list of historical versions of study NCT00686491 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Respiratory Health of Elite Athletes
Center of Excellence in CardioRespiratory Health of High-level Athletes: Evaluation of Long-term Effects of Training.

Eleven National Sports Teams are located in the Quebec Metropolitan Area. In these groups, many athletes are aiming for Olympic medals in Beijing 2008 and Vancouver 2010 Olympic Games. A consultation of the coaches of these National Teams revealed that although a large proportion of these athletes present various cardio-respiratory symptoms, they do not have a rapid access to a systematic medical evaluation and follow-up. Furthermore, little is done in regard to prevention and optimization of treatment of pulmonary and cardiac conditions in the elite athlete's population of the Quebec area.

Cardiorespiratory problems are therefore commonly found in high-level athletes. However, these pathologies are not well characterized in athletes and the associated symptoms often not well perceived. These problems can be serious and it is important to detect them before they appear1 while setting up a systematic medical follow-up. Health professionals should monitor health of the young athletes and help to reduce the risks associated with high level exercise. The following project is an evaluation and follow-up program of high-level athletes, aiming at gathering key-information on long-term effects of high-level training on cardio-respiratory and metabolic parameters. Our aims will be

  1. to establish a long-term program of systematic evaluation and follow-up of cardiorespiratory health and performance of high elite athletes.
  2. to evaluate the prevalence of respiratory, circulatory and metabolic problems among high-level athletes
  3. to evaluate the effects of treatments on cardiorespiratory conditions and exercise performance in athletes who need asthma medication.
Not Provided
Observational
Observational Model: Case Control
Time Perspective: Prospective
Not Provided
Retention:   Samples With DNA
Description:

Serum - plasma - sputum
Non-Probability Sample

Athletes training in the province of Quebec. Controls from Quebec schools and universities.
  • Asthma
  • Cardiovascular Diseases
  • Metabolic Diseases
Not Provided
  • 1
    Triathletes
  • 2
    Cold air athletes
  • 3
    Swimmers
  • 4
    Other sports elite athletes
  • 5
    Control subjects

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
133
December 2010
December 2010   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Athletes training more than 10 hours per week-

Exclusion Criteria:

  • asthma or other pathologies that may interfere with the study
  • Smokers
  • Obese of with a BMI more than 29
Both
14 Years to 45 Years
Yes
Contact information is only displayed when the study is recruiting subjects
Canada
 
NCT00686491
CER 20141
No
Dr Louis-Philippe BOULET, Institut universitaire de cardiologie et de pneumologie de Québec
Laval University
Not Provided
Principal Investigator: Paul POIRIER, MD Hôpital LAval
Laval University
February 2011

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP